Company news

Dante Genomics Unveils Digital Health Population Genomic Programs at the United Nations General Assembly Science Summit

Dante Genomics Unveils Digital Health Populatio...

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company’s co-founder and CEO Andrea Riposati presented...

Dante Genomics Unveils Digital Health Populatio...

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company’s co-founder and CEO Andrea Riposati presented...

Dante Genomics to innovate universal genomics by now offering easy, at-home blood collection kits for clinical whole genome sequencing without the use of a needle

Dante Genomics to innovate universal genomics b...

NEW YORK, September 1, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today that the Company has begun using needleless, at-home blood collection...

Dante Genomics to innovate universal genomics b...

NEW YORK, September 1, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today that the Company has begun using needleless, at-home blood collection...

Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates

Mainz Biomed e Dante Genomics annunciano la pie...

BERKELEY, California e MAINZ, Germania e NEW YORK, 16 agosto 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz" o la "Società"), una società di diagnostica genetica molecolare specializzata in...

Mainz Biomed e Dante Genomics annunciano la pie...

BERKELEY, California e MAINZ, Germania e NEW YORK, 16 agosto 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz" o la "Società"), una società di diagnostica genetica molecolare specializzata in...

Dante Genomics to Participate in a Panel Presentation at the Canaccord Genuity 42nd Annual Growth Conference

Dante Genomics to Participate in a Panel Presen...

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced that members of its management team will participate in the Canaccord Genuity...

Dante Genomics to Participate in a Panel Presen...

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced that members of its management team will participate in the Canaccord Genuity...

Dante Genomics partners with Emirates Post to deliver advanced genomic services in UAE

Dante Genomics partners with Emirates Post to d...

The partnership aims to enable universal access to genomic-driven wellness and longevity   June 22, 2022   Emirates Post, the official postal operator and leading express provider in the UAE,...

Dante Genomics partners with Emirates Post to d...

The partnership aims to enable universal access to genomic-driven wellness and longevity   June 22, 2022   Emirates Post, the official postal operator and leading express provider in the UAE,...

Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery

Dante Labs highlights advancements to its drug ...

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six drug candidates...

Dante Labs highlights advancements to its drug ...

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six drug candidates...